Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Alexandersen

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Atherosclerosis|April 6, 2004
The aging male: testosterone deficiency and testosterone replacement. An up-datePeter Alexandersen, Claus Christiansen
Women'S Health (London, England)|October 30, 2009
Long-term prevention with hormone-replacement therapy after the menopause: which women should be targeted?Peter Alexandersen, Morten A Karsdal, Claus Christiansen
Menopause (New York, N.Y.)|May 9, 2009
Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trialMatthias Schaefers, Christoph Muysers, Peter Alexandersen, et al.
Menopause (New York, N.Y.)|January 26, 2005
Early postmenopausal hormone therapy may prevent cognitive impairment later in lifeYu Z Bagger, László B Tankó, Peter Alexandersen, et al.
Bone|October 3, 2006
Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal womenPeter Alexandersen, M A Karsdal, Per Qvist, et al.
Bone|September 19, 2003
Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawalYu Z Bagger, László B Tankó, Peter Alexandersen, et al.
Obesity Research|October 16, 2004
The implications of body fat mass and fat distribution for cognitive function in elderly womenYu Z Bagger, László B Tankó, Peter Alexandersen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 16, 2004
Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic womenLászló B Tankó, Gerong Qin, Peter Alexandersen, et al.
Circulation|April 2, 2003
Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly womenLászló B Tankó, Yu Z Bagger, Peter Alexandersen, et al.
Human Reproduction (Oxford, England)|July 2, 2003
Lack of difference among progestins on the anti-atherogenic effect of ethinyl estradiol: a rabbit studyPeter Alexandersen, Jens Haarbo, Pieter Zandberg, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Atherosclerosis|April 6, 2004
The aging male: testosterone deficiency and testosterone replacement. An up-datePeter Alexandersen, Claus Christiansen
Women'S Health (London, England)|October 30, 2009
Long-term prevention with hormone-replacement therapy after the menopause: which women should be targeted?Peter Alexandersen, Morten A Karsdal, Claus Christiansen
Menopause (New York, N.Y.)|May 9, 2009
Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trialMatthias Schaefers, Christoph Muysers, Peter Alexandersen, et al.
Menopause (New York, N.Y.)|January 26, 2005
Early postmenopausal hormone therapy may prevent cognitive impairment later in lifeYu Z Bagger, László B Tankó, Peter Alexandersen, et al.
Bone|October 3, 2006
Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal womenPeter Alexandersen, M A Karsdal, Per Qvist, et al.
Bone|September 19, 2003
Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawalYu Z Bagger, László B Tankó, Peter Alexandersen, et al.
Obesity Research|October 16, 2004
The implications of body fat mass and fat distribution for cognitive function in elderly womenYu Z Bagger, László B Tankó, Peter Alexandersen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 16, 2004
Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic womenLászló B Tankó, Gerong Qin, Peter Alexandersen, et al.
Circulation|April 2, 2003
Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly womenLászló B Tankó, Yu Z Bagger, Peter Alexandersen, et al.
Human Reproduction (Oxford, England)|July 2, 2003
Lack of difference among progestins on the anti-atherogenic effect of ethinyl estradiol: a rabbit studyPeter Alexandersen, Jens Haarbo, Pieter Zandberg, et al.
Pageof 4